MOB

• Mechlorethamine
• Bleomycin
• Vincristine

Name

Mechlorethamine

Alternate Names

Chlorethazine Hydrochloride

Chlormethine Hydrochloride

Dichloromethyl-diethylamine-HCl

Mechlorethamine Hydrochloride

Meclorethamine

Mustargen

Mustargen-HCl

Mustine

Nitrogen Mustard

WR-147650

Valchlor

Abbreviations

HN2

NH2

NH2-HCl

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

000762

762

Primary Site

CLL

Cutaneous T-cell lymphoma (topical use)

Hodgkin lymphoma

lung cancer

Non-Hodgkin lymphoma

Histology

None

Remarks

FDA approved uses on bronchogenic carcinoma, chronic lymphocytic leukemia, Hodgkin's lymphoma, Non-Hodgkin lymphoma, lymphosarcoma, and malignant effusion.

Coding

This drug should be coded

Name

Bleomycin

Alternate Names

Blenoxane

Bleo

Bleo-Cell

Bleo-S

Bleomycin for Injection

Bleomycin sulfate

Oil Bleo

Abbreviations

BLE

BLEO

BLM

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

125066

Primary Site

Squamous cell cancers

Histology

None

Remarks

FDA approved uses on squamous cell cervical cancer, head & neck cancer, Hodgkin's and non-Hodgkin's lymphoma, nasopharyngeal cancer, carcinoma, and testicular cancer.

Coding

This drug should be coded

Name

Vincristine

Alternate Names

Compound 37231

Leurocristine Sulfate

Oncovin

Vincasar

Vincasar PFS

Vincristine Sulfate

Vincrystine

Vinkristin

Abbreviations

LCR

VCR

VNCR

Category

Chemotherapy

Subcategory

Plant alkyloid--antimetabolite

NSC Number

067574

67574

Primary Site

None

Histology

None

Remarks

Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.

Coding

This drug should be coded